-
How open dialogues are challenging harmful social norms in Kenya
Through the Youth for Health project, MSI Kenya conducts community dialogues to raise awareness about sexual and reproductive health for adolescents and challenge harmful social norms.
-
MSI named a ‘very high-performer’ in 2024 gender equity and inclusion report
In the latest Global Health 50/50 Report, which looks at the gender-related policies and practices of more than 200 organisations in global health, we’re proud that MSI has been rated a ‘very high performer’.
-
Rev. Cliff: I choose choice by using my power as a religious leader
Reverend Cliff is a minister of the church, and partners with MSI Malawi to fight for reproductive rights. He shares why religious leaders have a unique power to expand access to contraception and abortion.
-
MSI Statement on the Second Anniversary of Dobbs
The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.
-
Briefing: Choice on the Ballot
2024 is the biggest election year in history and reproductive rights hang in the balance.
-
New Guttmacher report shows long-term harms of US Global Gag Rule in Ethiopia and Uganda
The Guttmacher Institute today published a multi-year research study which reveals the U.S. Global Gag Rule (GGR) disrupted critical health services affecting women and girls in Uganda and Ethiopia – two countries that rely on U.S. assistance for their family planning programmes.
-
Advocacy win: Mifepristone registered in Tanzania
MSI and partners have successfully advocated to have mifepristone – the second of two medications used for abortion and post-abortion care – registered and authorised for use in Tanzania.
-
Digital Disparities: The global battle for reproductive rights on social media
Our report with the Centre for Countering Digital Hate finds that Meta and Google are blocking access to accurate information on abortion and wider reproductive healthcare in countries across Africa, Asia, and Latin America.
-
MSI Statement on U.S. Supreme Court Hearing on Mifepristone
The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.
-
We must protect frontline reproductive health providers from abuse
Our providers can face abuse, isolation and prosecution in their communities. As a sector, we must protect them.
